Brokerages Set Bath & Body Works, Inc. (NYSE:BBWI) Target Price at $43.19

Bath & Body Works, Inc. (NYSE:BBWI) has been assigned an average recommendation of “Moderate Buy” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and ten have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $43.19.

Several research analysts have commented on BBWI shares. Piper Sandler boosted their target price on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. JPMorgan Chase & Co. boosted their price target on Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a report on Friday, January 24th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a report on Monday, November 25th. Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th.

Bath & Body Works Stock Up 0.0 %

BBWI stock opened at $35.48 on Friday. The company has a market cap of $7.68 billion, a PE ratio of 8.65, a price-to-earnings-growth ratio of 0.90 and a beta of 1.83. Bath & Body Works has a 52 week low of $26.20 and a 52 week high of $52.99. The business has a 50-day simple moving average of $37.68 and a 200 day simple moving average of $33.66.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 earnings per share. On average, analysts anticipate that Bath & Body Works will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works’s payout ratio is 19.51%.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of Bath & Body Works by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company’s stock worth $1,093,306,000 after buying an additional 208,036 shares in the last quarter. FMR LLC raised its position in Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after buying an additional 2,501,828 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Bath & Body Works by 13.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company’s stock valued at $66,088,000 after purchasing an additional 195,813 shares during the period. KBC Group NV grew its stake in Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after purchasing an additional 1,683,160 shares during the period. Finally, Erste Asset Management GmbH grew its stake in shares of Bath & Body Works by 0.3% during the 4th quarter. Erste Asset Management GmbH now owns 1,585,460 shares of the company’s stock worth $61,546,000 after acquiring an additional 5,035 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.